Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gaboxadol for primary insomnia
NCT00103818Phase 3Completed
- Sponsor
- Lundbeck
- Start
- Feb 2005
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of gaboxadol in Insomnia, sponsored by Lundbeck. Started Feb 2005; status: completed.
02
Drugs
gaboxadol
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT00103818.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00103818.